CTRI/2021/03/032056
Recruiting
Phase 3
Assessment of inflammatory markers in patients with respiratory illness and the role of cardamom extract and 1-8 cineol in controlling associated inflammation
Zum Heilen Diagnostic Therapeutics ZH DT0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: J208- Acute bronchitis due to other specified organisms
- Sponsor
- Zum Heilen Diagnostic Therapeutics ZH DT
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Age group 19 â?? 70 yrs
- •2\.Subjects of both male and females involved
- •3\.Patients with acute respiratory infections
- •4\.Subjects who are willing to provide written consent for the study
- •5\.Mild to Moderately severe disease (NEWS score Less than/equal to 8\)
- •6\.Can take oral medicines
- •7\.Subject willing to abide by and comply with the study protocol
Exclusion Criteria
- •1\.Subjects less than 17 years and above 70yrs old
- •2\.Pregnancy and lactation
- •3\.Patients with existing history of other inflammatory disease conditions
- •4\.Patients currently taking anti\-inflammatory drugs and
- •5\.Immune\-compromised subjects
- •6\.Severe or complicated lung disease/infection
- •7\.Presence of acute hypoxic respiratory failure/ need for Intensive care unit (ICU) stay/ Patients who need mechanical ventilation.
- •8\.Any uncontrolled systemic disease, infection
- •9\.Those with serious Cardiovascular, Cerebrovascular, Respiratory, Liver or Renal disease or any other disorder.
- •10\.Other conditions, which in the opinion of the investigators makes the patient unsuitable for enrolment or could interfere in adherence to of the study protocol
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessment of inflammatory markers in patients with ulcerative colitis treated with tofacitinibulcerative colitis10017969NL-OMON40572Academisch Medisch Centrum30
Active, not recruiting
Phase 1
Examining the effects of eye drops on changes in inflammation on the surface of the eyeGlaucoma is the condition that is being treated by these eye drops - however the study is aimed at measuring the amount of inflammation that develops on the surface of the eye when these drops are usedMedDRA version: 14.1 Level: HLGT Classification code 10018307 Term: Glaucoma and ocular hypertension System Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2013-000581-10-GBottingham University NHS Trust100
Completed
Not Applicable
Examination of inflammatory markers associated with Total Knee Replacement surgery, and the association with coagulopathies (bleeding/clotting disorders)ACTRN12617000444381Orthopaedic Research Institute of Queensland (ORIQL)20
Active, not recruiting
Phase 1
Evaluation of inflammatory markers in patients undergoing a short-term aerobic exercise program while hospitalized due to acute exacerbation of COPDChronic obstructive pulmonary disease with acute lower respiratory infectionJ44.0RBR-7yv765Faculdade de Medicina de Botucatu /UNESP
Not yet recruiting
Not Applicable
Comparing occurrence of dry eye following cataract surgery by phacoemulsification and MSICSCTRI/2021/08/035502JIPMER